CHM Cannabis
Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

As if they never mentioned many of their

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Its_lose_not_loose Member Profile
Member Level 
Followed By 8
Posts 5,408
Boards Moderated 0
Alias Born 09/11/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2018 4:39:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 4:38:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2018 5:23:31 PM
NanoViricides, Inc. Appoints Mr. James Sapirstein to its Board of Directors PR Newswire (US) - 10/29/2018 7:00:00 AM
NanoViricides CEO Dr. Irach Taraporewala Presents a Letter to Shareholders PR Newswire (US) - 10/22/2018 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/19/2018 4:36:17 PM
NanoViricides Has Filed its Annual Report, Company Reports Strong Progress in Advancement of HerpeCide Program PR Newswire (US) - 10/15/2018 7:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 10/12/2018 4:51:39 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/12/2018 6:05:20 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/11/2018 5:24:24 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 9/28/2018 5:49:02 PM
NanoViricides Inc. to Present at the MicroCap Conference in New York City on October 1 PR Newswire (US) - 9/28/2018 7:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/12/2018 6:05:23 AM
NanoViricides Inc. to Present at 20th Annual Rodman & Renshaw Conference in NYC on Sept 6th PR Newswire (US) - 9/5/2018 7:00:00 AM
NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study PR Newswire (US) - 8/7/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2018 4:44:51 PM
NanoViricides, Inc. Welcomes Dr. Irach Taraporewala as the New CEO PR Newswire (US) - 7/23/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2018 6:04:09 AM
NanoViricides Provides Update on Recent Events PR Newswire (US) - 7/12/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/11/2018 6:05:20 AM
Progress of NanoViricides' Shingles Drug Program Presented at the 31st International Conference on Antiviral Research PR Newswire (US) - 6/26/2018 7:00:00 AM
NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and I... PR Newswire (US) - 5/22/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/21/2018 4:22:22 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2018 4:33:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/4/2018 6:07:03 PM
Its_lose_not_loose Member Level  Friday, 11/10/17 07:02:16 PM
Re: leifsmith post# 135939
Post # of 141064 
As if they never mentioned many of their countless other failures or misrepresentations.

It would be dangerous to invest in NNVC at this juncture.


"Who would claim to be one who was not?"
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist